Latest News

Latest Update on Urgent Virus Outbreaks: June 2024 Dialogue Now Open For Registration June 11, 2024 10:00 AM – 11:00 AM PT   IAS–USA Dialogues (formerly COVID-19 Dialogues) were created to address an urgent need for reliable scientific information, with understanding of SARS-CoV-2 and COVID-19 disease changing almost daily. In response, the IAS−USA created a program [...]

We are excited to announce a collaboration between the IAS–USA and the World Congress of Epidemiology 2024. The partnership is in support of the state-of-the-art HIV Epidemiology content at WCE2024, which will be held in Cape Town, South Africa on September 24 to 27, 2024. A combination of workshops, symposia, interactive sessions, and abstract-driven content […]

The on-demand webcasts for the 2024 Scott M. Hammer Annual Update on HIV Management in New York, NY, are now available. This enduring activity offers up to 6.0 CME credits. Continuing Education Credits CME Credits The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical [...]

All registered attendees received an email on Thursday, March 7, with instructions on how to claim CME credits, ABIM MOC points, or a certificate of participation. These instructions are also available on the CME page.

Thank you for attending the 2024 Conference on Retroviruses and Opportunistic Infections! We hope you enjoyed this year’s rich scientific program of new research findings, state-of-the-art plenary talks, lively interactive sessions, and comprehensive symposia. CROI 2025 will be held in San Francisco, California from March 9 to 12. Hope to see you again next year!

The IAS-USA is deeply saddened by the passing of John P. Phair, MD, on February 19, 2024. John P. Phair, MD, Professor of Medicine, Emeritus, Northwestern University Medical School, Chicago, IL, was the first recipient of the International AIDS Society–USA (IAS–USA) Lifetime Leadership Award. He was honored on April 19, 2010, at the IAS–USA annual [...]

In a letter to JAMA published today, March 1, the IAS–USA Guidelines Panel provided its HIV treatment recommendation on the use of cabotegravir and rilpivirine. To learn more about this most recent update, click here. Read the Letter Here

Latest Update on Urgent Virus Outbreaks: March 2024 Dialogue March 26, 2024 10:00 AM – 11:00 AM PT IAS–USA Dialogues (formerly COVID-19 Dialogues) were created to address an urgent need for reliable scientific information, with understanding of SARS-CoV-2 and COVID-19 disease changing almost daily. In response, the IAS−USA created a program that brought together leading […]

Application and Registration for CROI 2024 is now closed. There may be a limited number of registrations available due to cancellations. If you wish to apply or register, please email the request to CROIregistration@iasusa.org.

Presenter: Melanie A. Thompson, MD Thacker & Thompson, MD Moderator: Rajesh T. Gandhi, MD Harvard Medical School Friday, March 29, 2024 12:00 PM – 1:15 PM PT Innovative medications for the treatment of people with HIV-1 continue to undergo rigorous research and development. This webinar will discuss current data around the latest pharmacologic treatments for […]